How does the USPTO handle defective sequence listings in patent applications filed after January 1, 2022?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. For patent applications filed on or after January 1, 2022,…

Read More

How does the USPTO handle cumulative information in supplemental examination?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The USPTO’s handling of cumulative information in supplemental examination is…

Read More

How does the USPTO handle confidential concurrent proceedings during reexamination?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The USPTO has specific procedures for handling confidential concurrent proceedings…

Read More

How does the USPTO handle questions of compliance with the duty of disclosure in inter partes reexamination?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The USPTO’s approach to handling questions of compliance with the…

Read More

How does the USPTO handle claims that potentially cover inoperative embodiments?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The USPTO’s approach to claims that potentially cover inoperative embodiments…

Read More

How does the USPTO handle benefit claims in international design applications?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The USPTO handles benefit claims in international design applications according…

Read More